Evolution of melanoma therapies from advanced to (neo)adjuvant (Alexander Eggermont)
Channel: НМИЦ онкологии им. Н.Н. Петрова
Date: 2022-01-06

Alexander M.M. Eggermont, MD, PhD. Chief Scientific Officer, Board of Directors Professor Clinical&Translational Immunotherapy, UMCU, Utrecht University Eur J Cancer Editor in Chief, Utrecht, Netherlands

Telegram https://t.me/niioncologii
YouTube https://www.youtube.com/niioncologii
Facebook https://www.facebook.com/niioncologii
VK https://vk.com/niioncologii
Instagram https://www.instagram.com/niioncologii